Krystal Biotech (KRYS) Change in Cash (2016 - 2026)

Krystal Biotech has reported Change in Cash for 11 years, with the latest figure at -$73.6 million in Q2 2026.

• Change in Cash for Q2 2026 came in at -$73.6 million, down 263.28% year-over-year; the trailing twelve-month figure through Jun 2026 was $73.9 million (up 818.95% YoY), and the FY2025 annual result was $151.4 million, up 1224.85% from the prior year.
• Change in Cash fell to -$73.6 million in Q2 2026, from $5.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $135.1 million in Q2 2023 and troughed at -$73.6 million in Q2 2026.
• A 5-year average of $4.8 million and a median of -$14.1 million in 2023 frame the typical range for Change in Cash.
• The largest YoY upside for Change in Cash was 456.35% in 2025 against a maximum downside of 5423.75% in 2025.
• A 5-year view of Change in Cash shows it stood at -$24.5 million in 2022, then jumped by 39.15% to -$14.9 million in 2023, then sank by 95.14% to -$29.1 million in 2024, then surged by 456.35% to $103.7 million in 2025, then sank by 170.95% to -$73.6 million in 2026.
• Per Business Quant data, the three most recent Change in Cash figures were -$73.6 million in Q2 2026, $5.0 million in Q1 2026, and $103.7 million in Q4 2025.